Dr. Gallant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
AXCES Research/Health
531 Harkle Road, Suite B
Santa Fe, NM 87505- Is this information wrong?
Summary
- I am board certified in internal medicine and infectious diseases, with expertise in the treatment and prevention of HIV infection.
Education & Training
Johns Hopkins School of Hygiene and Public HealthMPH, Internaional Health, John C. Hume Masters in Public Health Award, Delta Omega Public Health Honor Society, 1989 - 1990
Yale-New Haven Medical CenterResidency, Internal Medicine, 1985 - 1988
University of California San Francisco School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 2019 - 2025
NM State Medical License 2012 - 2019
MD State Medical License 1989 - 2014- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- HIV Clinical Educator Award HIV Medicine Association and Infectious Disease Society of America
Publications & Presentations
PubMed
- 4 citationsPlasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimen...Álvarez, H., Mocroft, A., Ryom, L., Neesgaard, B., Edwards, S., Svedhem, V., Günthard, H., Zangerle, R., Smith, C., Castagna, A., d'Arminio Monforte, A., Wit, F., Stec...> ;Clinical Infectious Diseases. 2023 Aug 22
- 9 citationsBictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed peo...Franco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina, Federico Pulido, Stephane De Wit, Linos Vandekerckhove, Juan Berenguer, Michelle L D'Antoni, Christiana Blair...> ;HIV Medicine. 2023 Jan 1
- 6 citationsHigh efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I.Paul E Sax, Kristen Andreatta, Jean-Michel Molina, Eric S Daar, Debbie Hagins, Rima Acosta, Michelle L D'Antoni, Silvia Chang, Ross Martin, Hui Liu, Christiana Blair, ...> ;AIDS. 2022 Sep 1
- Join now to see all
Lectures
- 23rd Annual Clinical Care of the Patient with HIV InfectionThe Johns Hopkins University School of Medicine, Baltimore, Maryland - 3/18/2013
Other
- Primer on interpretation of HIV drug resistance testingGallant JE, Cohen CJ
http://www.uptodate.com/contents/primer-on-interpretation-of-hiv-drug-resistance-testing
UpToDate, Wolters Kluwer Health - 2012-09-20
Press Mentions
Biktarvy Could Be Long-Term Option for Older Adults With HIVOctober 6th, 2022
Bareback: Re-Opening the Dialogue on Safer Sex in the Age of U=UMarch 5th, 2018
Gilead Announces Phase 3 Results for Investigational Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIVJuly 24th, 2017- Join now to see all
Grant Support
- ACTG A5202National Center For Research Resources2006–2007
- ACTG A5142National Center For Research Resources2004–2007
- AIDS Related Nonhodgkin'S Lymphoma/Kaposi'S Sarcoma And Other MalignanciesNational Center For Research Resources1998–2002
- Phase II Safety, Plasma Pharmacokinetics &AntiretroviralNational Center For Research Resources1999
Professional Memberships
- Fellow
- Fellow
Other Languages
- Spanish
Industry Relationships
- Executive Director, Global Medical FfIrs, Gilead Sciences2017 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
